Fennec Pharmaceuticals Inc FENC Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$9.83 up $0.44, 4.69% on Nov 6
Last price · Previous close $9.39
- Market cap
- At the last price
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$9.83up $0.44, 4.69%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$9.39Nov 5
- Volume161.80KNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume131.51KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $5.65 to $13.25; now $9.83
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the last price. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
FENC beat the S&P 500 in 4 of 7 periods.
| Period | FENC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | FENC: down 5.0% S&P 500: down 5.6% | FENC beat the S&P 500 by 0.6 percentage points Beat |
| 3M | FENC: down 9.3% S&P 500: down 4.1% | FENC trailed the S&P 500 by 5.2 percentage points Trailed |
| YTD | FENC: up 27.7% S&P 500: up 8.7% | FENC beat the S&P 500 by 19.0 percentage points Beat |
| 1Y | FENC: up 22.9% S&P 500: up 10.9% | FENC beat the S&P 500 by 12.0 percentage points Beat |
| Long term | ||
| 3Y | FENC: up 23.5% S&P 500: up 75.0% +7.3% vs +20.5% a year | FENC trailed the S&P 500 by 51.5 percentage points Trailed |
| 5Y | FENC: up 5.1% S&P 500: up 67.8% +1.0% vs +10.9% a year | FENC trailed the S&P 500 by 62.7 percentage points Trailed |
| 10Y | FENC: up 386.6% S&P 500: up 313.1% +17.1% vs +15.2% a year | FENC beat the S&P 500 by 73.5 percentage points Beat |
$10,000 invested in FENC 10 years ago (Nov 4, 2016) would be worth about $48,663 as of , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
FENC beat the S&P 500 in 4 of 7 periods.
| Period | FENC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | FENC: down 5.0% S&P 500: down 5.6% | FENC beat the S&P 500 by 0.6 percentage points Beat |
| 3M | FENC: down 9.3% S&P 500: down 4.3% | FENC trailed the S&P 500 by 5.0 percentage points Trailed |
| YTD | FENC: up 27.7% S&P 500: up 7.8% | FENC beat the S&P 500 by 19.9 percentage points Beat |
| 1Y | FENC: up 22.9% S&P 500: up 9.7% | FENC beat the S&P 500 by 13.2 percentage points Beat |
| Long term | ||
| 3Y | FENC: up 23.5% S&P 500: up 68.8% +7.3% vs +19.1% a year | FENC trailed the S&P 500 by 45.3 percentage points Trailed |
| 5Y | FENC: up 5.1% S&P 500: up 56.9% +1.0% vs +9.4% a year | FENC trailed the S&P 500 by 51.8 percentage points Trailed |
| 10Y | FENC: up 386.6% S&P 500: up 252.6% +17.1% vs +13.4% a year | FENC beat the S&P 500 by 134.0 percentage points Beat |
$10,000 invested in FENC 10 years ago (Nov 4, 2016) would be worth about $48,663 as of , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$14.33
Closing high on . Now 31.4% below that record.
Split-adjusted daily closes since Sep 9, 2014.
Stock splits
FENC hasn’t split since its price history begins in 2014.
Valuation
Financials
About Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals, Inc
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
FENC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
FENC stock FAQ
What is FENC stock’s price today?
Fennec Pharmaceuticals (FENC) traded at $9.83 as of , up $0.44 (4.69%) from the previous close of $9.39. Over the past 52 weeks it has traded between $5.65 and $13.25.
If you invested $1,000 in FENC 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in FENC on would be worth about $4,866 as of , a total return of +386.6%. The same $1,000 would be worth $1,051 if invested five years ago and $1,229 if invested one year ago. Past performance doesn’t predict future returns.
Does FENC pay a dividend?
Fennec Pharmaceuticals hasn’t paid a dividend in the last twelve months.
What is FENC’s 52-week high and low?
Over the past 52 weeks FENC has traded as low as $5.65 and as high as $13.25. At $9.83 as of , it is 25.8% below that high and 74.0% above the low.
What is FENC’s all-time high?
FENC’s highest closing price was $14.33 on , adjusted for stock splits. At $9.83 as of , it is 31.4% below that record.
Has FENC stock ever split?
No. FENC hasn’t split since its price history begins in 2014.
How has FENC stock performed?
Including dividends and measured to the last price on , FENC has returned +27.7% so far this year and +22.9% over the past year, and +5.1% over five years (+1.0% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What exchange does FENC trade on?
Fennec Pharmaceuticals trades on the Nasdaq under the ticker symbol FENC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.